Drug: rituximab Quarter: 2016Q3
Total Records: 1,104 Number of Pages: 56
| DRUGNAME | PT | EventCount |
|---|---|---|
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Sepsis | 3 |
| RITUXIMAB | Abdominal sepsis | 2 |
| Rituximab | Abscess soft tissue | 2 |
| Rituximab | Acute generalised exanthematous pustulosis | 2 |
| Rituximab | Acute hepatic failure | 2 |
| rituximab | Acute lymphocytic leukaemia | 2 |
| RITUXIMAB | Ankle operation | 2 |
| Rituximab | Anogenital warts | 2 |
| Rituximab | Aplastic anaemia | 2 |
| RITUXIMAB | Ascites | 2 |
| Rituximab | Autoimmune colitis | 2 |
| RITUXIMAB | B precursor type acute leukaemia | 2 |
| Rituximab | Bacteraemia | 2 |
| Rituximab | Bacterial infection | 2 |
| RITUXIMAB | Bile duct obstruction | 2 |
| Rituximab | Bile duct stone | 2 |
| Rituximab | Blister | 2 |
| RITUXIMAB | Blood alkaline phosphatase increased | 2 |
| Rituximab | Blood pressure increased | 2 |
| Rituximab | Blood sodium decreased | 2 |
Total Records: 1,104 Number of Pages: 56